CODEXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.05 USD | +14.66% |
|
+6.64% | 0.00% |
| 11/04 | Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board | CI |
| 29/02 | Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9 | MT |
Chart calendar Codexis, Inc.
8e632946693204c745fa12294.ON-E1knmE7Dh5VTkb8SKJEg6Ps0pCvygO1zQNC1LwMo.Z-f8jguMcvOJsWKDOaztYnFIZIpoX62NVgieWmo6pK4BtvyiZJ8l9oqQOw~0866fb2a73eea4aca8200ee0c63e820d
Upcoming events on Codexis, Inc.
Past events on Codexis, Inc.
| 05/03/2024 01:20 am | TD Cowen Health Care Conference |
| 29/02/2024 03:00 am | Q4 2023 Earnings Call |
| 29/02/2024 02:35 am | Q4 2023 Earnings Release |
| 14/02/2024 03:00 am | Business Update Call |
| 08/02/2024 03:15 am | Advances in Genome Biology and Technology General Meeting - Poster No – 505 |
| 08/12/2023 08:30 pm | Investor Meeting - Key Opinion Leader |
| 28/11/2023 08:00 pm | Piper Sandler Healthcare Conference |
| 16/11/2023 | Craig-Hallum Alpha Select Conference |
| 15/11/2023 08:30 pm | Stephens Investment Conference |
| 14/11/2023 07:40 pm | Stifel Healthcare Conference |
| 14/11/2023 06:30 pm | Jefferies London Healthcare Conference |
| 03/11/2023 02:00 am | Q3 2023 Earnings Call |
| 03/11/2023 01:35 am | Q3 2023 Earnings Release |
| 01/11/2023 05:55 pm | TIDES Europe Meeting |
| 26/09/2023 06:50 pm | Cantor Global Healthcare Conference |
| 04/08/2023 01:35 am | Q2 2023 Earnings Release |
| 21/07/2023 02:00 am | Business Update Call |
| 13/06/2023 09:30 pm | Annual General Meeting |
| 07/06/2023 10:30 pm | Jefferies Global Healthcare Conference |
| 07/05/2023 | TIDES Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 68,5 71,2 -3.9% | 69,1 68,9 0.23% | 105 103 1.29% | 139 137 1.05% | 70,1 61,7 13.74% | 65,4 |
|
EBITDA Million USD | Released Forecast Spread | -4,04 -2,79 -44.87% | -14,2 -16,9 15.97% | -7,99 -22,7 64.85% | -29,5 -26,3 -11.96% | -62,6 -59,2 -5.59% | -35,4 |
|
EBIT Million USD | Released Forecast Spread | -12,5 -11,6 -7.84% | -23,9 -27,3 12.47% | -22,7 -25,1 9.44% | -34,9 -35,3 1.22% | -68,1 -78,0 12.69% | -48,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,9 -11,3 -5.36% | -23,7 -26,9 11.9% | -21,1 -25,0 15.74% | -33,3 -35,2 5.36% | -76,2 -82,0 7.09% | -47,0 |
|
Net income Million USD | Released Forecast Spread | -11,9 -11,3 -6.07% | -24,0 -27,3 12.12% | -21,3 -25,1 15.31% | -33,6 -35,9 6.33% | -76,2 -81,7 6.72% | -46,0 |
|
EPS USD | Released Forecast Spread | -0,21 -0,20 -5% | -0,40 -0,46 13.36% | -0,33 -0,38 14.13% | -0,51 -0,55 6.85% | -1,12 -1,18 4.95% | -0,64 |
| Announcement Date | 27/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,5 23,1 5.85% | 35,3 28,6 23.63% | 38,4 37,9 1.43% | 34,5 30,9 11.41% | 30,4 28,9 5.02% | 13,0 14,1 -7.88% | 21,3 21,3 -0.07% | 9,28 10,0 -7.48% | 26,6 18,1 46.8% | 13,3 | 12,0 | 16,2 | 23,9 | 12,6 |
|
EBITDA Million USD | Released Forecast Spread | -6,37 -14,0 54.5% | -3,33 -11,1 70.1% | 1,96 -8,39 123.39% | -4,70 -11,0 57.27% | -8,88 -13,2 32.6% | -19,4 -18,6 -4.29% | -8,36 -8,43 0.8% | -27,3 -22,3 -22.13% | 1,50 -6,57 122.82% | -11,0 | -12,2 | -10,5 | -1,75 | |
|
EBIT Million USD | Released Forecast Spread | -10,4 -13,2 21.41% | -8,39 -12,3 31.93% | -2,61 -8,76 70.2% | -10,6 -11,9 10.74% | -13,3 -14,9 10.95% | -23,7 -19,9 -18.96% | -12,6 -16,0 21.78% | -32,1 -24,3 -31.86% | 0,28 -12,9 102.19% | -13,8 | -15,3 | -12,1 | -8,55 | -11,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,1 -14,1 28.05% | -8,35 -12,5 33.26% | -2,53 -8,58 70.5% | -9,98 -12,6 20.57% | -12,5 -14,3 13.18% | -22,6 -19,7 -14.71% | -11,5 -14,3 19.38% | -34,9 -23,3 -49.6% | -7,16 -13,0 44.85% | -13,4 | -14,8 | -11,7 | -8,25 | -11,6 |
|
Net income Million USD | Released Forecast Spread | -10,2 -13,2 22.57% | -8,36 -12,6 33.46% | -2,64 -8,81 70.03% | -9,99 -12,1 17.62% | -12,6 -14,9 15.26% | -22,6 -19,7 -14.69% | -11,5 -14,0 17.82% | -34,9 -22,5 -54.94% | -7,19 -12,4 41.98% | -13,2 | -14,8 | -11,7 | -7,01 | -11,6 |
|
EPS USD | Released Forecast Spread | -0,16 -0,20 20% | -0,13 -0,19 30.2% | -0,04 -0,14 71.43% | -0,15 -0,19 19.46% | -0,19 -0,23 16.02% | -0,34 -0,31 -10.12% | -0,17 -0,21 19.69% | -0,50 -0,32 -54.18% | -0,10 -0,15 34.78% | -0,18 | -0,21 | -0,17 | -0,09 | -0,17 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | - | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Codexis, Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CDXS Stock
- Calendar Codexis, Inc.
